Of the T-cell lymphoma populations, 98 (80%) were CD4-positive, 12 (10%) were CD4/CD8-double-negative, 11 (9%) were CD8-positive and 1 (1%) was CD4/CD8-doublepositive (Figure 3B,C). The gene discussed is CD8A; the disease is T-cell non-Hodgkin lymphoma.